Abstract
Clinical features and therapeutical approaches in 10 cases of membranous glomerulonephritis (MGN) have been reviewed in an attempt to identify predictive indices of prognosis, and features distinguishing between idiopathic and hepatitis B surface antigen (HBsAg) related forms of glomerulopathy. Five of these children (age range 8-10 years) had HBsAg associated MGN and the other five (age range 12-16) lacking this antigen were defined as idiopathic MGN. The follow up was nine months to 10 years (mean 4.3 years). All had nephrotic syndrome during the course of their disease. There were no distinguishing clinical features nor any difference in the outcome between these two groups. None of the clinical findings including the presence of HBsAg, adversely affected outcome. All patients in the idiopathic group and three of the five in the HBsAg related group received immunosuppressive treatment. Overall complete remission was achieved in four of the five HBsAg associated patients and in three of the idiopathic patients plus partial remission in one of each group. Immunosuppressive treatment caused no complications, and beneficial results of the treatment particularly in the idiopathic MGN group were observed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Furuse A., Hattori S., Terashima T., Karashima S., Matsuda I. Circulating immune complex in glomerulonephropathy associated with hepatitis B virus infection. Nephron. 1982;31(3):212–218. doi: 10.1159/000182649. [DOI] [PubMed] [Google Scholar]
- Hoofnagle J. H., Davis G. L., Pappas S. C., Hanson R. G., Peters M., Avigan M. I., Waggoner J. G., Jones E. A., Seeff L. B. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1986 Jan;104(1):12–17. doi: 10.7326/0003-4819-104-1-12. [DOI] [PubMed] [Google Scholar]
- Kleinknecht C., Levy M., Peix A., Broyer M., Courtecuisse V. Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr. 1979 Dec;95(6):946–952. doi: 10.1016/s0022-3476(79)80281-4. [DOI] [PubMed] [Google Scholar]
- Latham P., Poucell S., Koresaar A., Arbus G., Baumal R. Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study. J Pediatr. 1982 Nov;101(5):682–685. doi: 10.1016/s0022-3476(82)80290-4. [DOI] [PubMed] [Google Scholar]
- Ponticelli C., Zucchelli P., Imbasciati E., Cagnoli L., Pozzi C., Passerini P., Grassi C., Limido D., Pasquali S., Volpini T. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1984 Apr 12;310(15):946–950. doi: 10.1056/NEJM198404123101503. [DOI] [PubMed] [Google Scholar]
- Ramirez F., Brouhard B. H., Travis L. B., Ellis E. N. Idiopathic membranous nephropathy in children. J Pediatr. 1982 Nov;101(5):677–681. doi: 10.1016/s0022-3476(82)80289-8. [DOI] [PubMed] [Google Scholar]
- Slusarczyk J., Michalak T., Nazarewicz-de Mezer T., Krawczyński K., Nowosławski A. Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol. 1980 Jan;98(1):29–43. [PMC free article] [PubMed] [Google Scholar]
- Takekoshi Y., Tanaka M., Shida N., Satake Y., Saheki Y., Matsumoto S. Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet. 1978 Nov 18;2(8099):1065–1068. doi: 10.1016/s0140-6736(78)91801-9. [DOI] [PubMed] [Google Scholar]